Arterial gene therapy for restenosis

Human Gene Therapy

Volumn 7, Issue 8, 1996, Pages 989-1011

  Isner, Jeffrey M ^a   Walsh, Ken ^a   Rosenfield, Kenneth ^a   Schainfeld, Robert ^a   Asahara, Takayuki ^a   Hogan, Kathleen ^a   Pieczek, Ann ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ADULT; ARTERY CATHETERIZATION; ARTICLE; BLOOD VESSEL; CARDIOVASCULAR SYSTEM; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG THERAPY; FEMALE; GENE SEQUENCE; GENE THERAPY; HUMAN; HYDROGEL; LEG; LEG REVASCULARIZATION; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL CIRCULATION; PLASMID; RESTENOSIS; REVASCULARIZATION; SUPERFICIAL FEMORAL ARTERY;

EID: 0029951420     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.8-989     Document Type: Article

References (108)

1. Palmaz JC, Richter GM, Noeldge G: Intraluminal stents in atherosclerotic iliac artery stenosis: preliminary report of multicenter study. Radiol 1988;168:727-731.
2. Gunther RW, Vorwerk D, Bohndorf K, Peters I, El-Din A, Messimer B: Iliac and femoral artery stenoses and occlusions: treatment with intravascular stems. Radiol 1989;172:725-730.
3. Rees CR, Palmaz JC, Garcia O, Roeren T, Richter GM, Gardiner G, Jr., Schwarten D, Schatz RA, Root HD, Rogers W: Angioplasty and stenting of completely occluded iliac arteries. Radiol 1989;172:953-959.
4. Becker GJ, Palmaz JC, Rees CR: Angioplasty-induced dissections in human iliac arteries: management with Palmaz balloon-expandable intraluminal stents. Radiol 1990;176:31-38.
5. Pieczek AM, Langevin RE, Jr., Razvi S, Rosenfield K: Successful percutaneous revascularization of 180/190 (95%) consecutive peripheral arterial total occlusions using hydrophilic ("Glide") wire. Circulation 1992;86:I-704. (abstract)
6. Krepel VM, vanAndel HJ, vanErp WFM, Breslau BJ: Percutaneous transluminal angioplasty of the femoropopliteal artery: initial and long-term results. Radiol 1985;165:325-328.
7. Hewes RC, White RI, Murray RR: Long-term results of superficial femoral artery angioplasty. AJR 1986;146:1025-1029.
8. Johnson KW, Rae M, Hogg-Johnston SA: Five year results of a prospective study of percutaneous transluminal angioplasty. Ann Surg 1987;206:403-413.
9. Gallino A, Mahler F, Probst P, Nachbur B: Percutaneous transluminal angioplasty of the arteries of the lower limbs: a 5-year follow-up. Circulation 1984;70:619-623.
10. Johnston KW: Femoral and popliteal arteries: reanalysis of results of balloon angioplasty. Radiol 1992;183:767-771.
11. Zeitler E, Richter EL, Roth FJ, Schoop W: Results of percutaneous transluminal angioplasty. Radiol 1983;146:57-60.
12. Morgenstern BR, Getrajdman GI, Laffey KJ, Bison R, Martin EC: Total occlusions of the femoropopliteal artery: high technical success rate of conventional balloon angioplasty. Radiol 1989;172:937-940.
13. Adar R, Critchfield GC, Eddy DM: A confidence profile analysis of the results of femoropopliteal percutaneous transluminal angioplasty in the treatment of lower-extremity ischemia. J Vasc Surg 1989;10:57-67.
14. vonPolnitz A, Nerlich A, Berger H, Hofling B: Percutaneous peripheral atherectomy: angiographic and follow-up of 60 patients. JACC 1990;15:682-688.
15. Dorros G, Lyer S, Lewin R, Zaitoun R, Mathiak L, Olson K: Angiographic follow-up and clinical outcome of 126 patients after percutaneous directional atherectomy (Simpson AtheroCath™) for occlusive peripheral vascular disease. Cathet Cardiovasc Diag 1991;22:79-84.
16. Kim D, Gianturco LE, Porter DH, Orron DE, Kuntz RE, Kent KC, Siegel JB, Schlam BW, Skillman JJ: Peripheral directional atherectomy: 4-year experience. Radiol 1992;183:773-778.
17. Dorros G, Lyer S, Zaitoun R, Lewin R, Cooley R, Olson K: Acute angiographic and clinical outcome of high speed percutaneous rotational atherectomy (Rotablator). Cathet Cardiovasc Diag. 1991;22:157-166.
18. Zacca NM, Raizner AE, Noon GP: Treatment of symptomatic peripheral atherosclerotic disease with a rotational atherectomy device. Am J Cardiol 1989;63:77-80.
19. Rousseau HP, Raillat CR, Joffre FG, Knight CJ, Ginested MD: Treatment of femoropopliteal stenoses by means of self-expandable endoprostheses: midterm results. Radiol 1989;172:961-964.
20. Sapoval MR, Long AL, Raynaud AC, Beyssen BM, Fiessinger J-N, JeGaux J-C: Femoropopliteal stent placement: long-term results. Radiol 1992;184:833-839.
21. Rosenfield K, Schainfeld R, Khan W, Pieczek A, Grail E, McGarr S, Isner JM: Restenosis of stented dialysis conduits caused by stent collapse, not neointimal proliferation. J Am Coll Cardiol 1995;25:262A. (abstract)
22. Asahara T, Bauters C, Pastore CJ, Kearney M, Rossow S, Bunting S, Ferrara N, Symes JF, Isner JM: Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation 1995;91:2793-2801.
23. 165 (Submitted), (UnPub)
24. Scott-Burden T, Vanhoutte PM: The endothelium as a regulator of vascular smooth muscle proliferation. Circulation 1993;87: V51-V-55.
25. Hanke H, Strohschneider T, Oberhoff M, Betz E, Karsch KR: Time course of smooth muscle cell proliferation in the intima and media of arteries following experimental angioplasty. Circulation 1990;67:651-659.
26. Webster S, Biship SP, Geer JC: Experimental aortic intimal thickening I: morphology and source of intima. Am J Pathol 1974;76:245-264.
27. Booth RFG, Martin JF, Honey AC, Hassall DG, Beesley JE, Moncada S: Rapid development of atherosclerotic lesions in the rabbit carotid artery induced by perivascular manipulation. Atherosclerosis 1989;76:257-268.
28. Clowes AW, Collazzo RE, Karnovsky MJ: A morphologic and permeability study of luminal smooth muscle cells after arterial injury in the rat. Lab Invest 1978;39:141-150.
29. Bjorkerud S, Bondjers G: Arterial repair and atherosclerosis after mechanical injury, part 5: tissue response after induction of a large superficial transverse injury. Atherosclerosis 1973;18: 235-255.
30. Fishman JA, Ryan GB, Karnovsky JM: Endothelial regeneration in the rat carotid artery and the significance of endothelial denudation in the pathogenesis of myointimal thickening. Lab Invest 1975;32:339-351.
31. Haudenschild CC, Schwartz SM: Endothelial regeneration, II: restitution of endothelial continuity. Lab Invest 1979;41:407-418.
32. Ross R: Atherosclerosis: a defense mechanism gone awry. Am J Pathol 1993;143:985-1002.
33. Haudenschild CC, Quist WC, LoGerfo FW: Protection of endothelium in vessel segments excised for grafting. Circulation 1981;64:II-101-II-107.
34. LoGerfo FW, Quist WC, Cantelmo NL, Haudenschild CC: Integrity of vein grafts as a function of initial and medial preservation. Circulation 1983;68:II-117-II-124.
35. Berinyi LK, Conte MS, Mullitan RC: Repopulation of injured arteries with genetically modified endothelial cells. J Vasc Surg 1992;15:932-934.
36. Nabel EG, Plautz G, Boyce FM, Stanley JC, Nable GJ: Recombinant gene expression in vivo within endothelial cells of the arterial wall. Science 1989;244:1342-1344.
37. Clowes AW, Gown AM, Hanson SR, Reidy MA: Mechanisms of arterial graft failure. 1. Role of cellular proliferation in early healing of PTFE prostheses. Am J Pathol 1985;118:43-54.
38. Stanley JC, Ford JW, Vinter DW, Kahn RH, Whitehouse WJ Jr, Graham LM: Enhanced patency of small-diameter, externally supported Dacron iliofemoral grafts seeded with endothelial cells. Surg 1982;92:994-1005.
39. Herring MB, Compton RS, LeGrand DR, Gardner AL, Madison DL, Blover DL: Endothelial seeding of polytetrafluoroethylene popliteal bypass: a preliminary report. J Vasc Surg 1987;6:114-118.
40. Wilson JM, Birinyi LK, Salomon RN, Libby P, Callow AD, Mullingan RC: Implantation of vascular grafts lined with genetically modified endothelial cells. Science 1989;244:1344-1346.
41. Van der Giessen WJ, Serruys PW, Visser WJ, Verdouw PD, van Schalkwijk WP, Jongkind JF: Endothelialization of intravascular stents. J Intervent Cardiol 1988;1:109-120.
42. Dichek DA, Neville RF, Zwiebel JA, Freeman SM, Leon MB, Anderson WF: Seeding of intravascular stents with genetically engineered endothelial cells. Circulation 1989;80:1347-1353.
43. Lindner V, Majack RA, Reidy MA: Basic fibroblast growth factor stimulates endothelial regrowth and proliferation in denuded arteries. J Clin Invest 1990;85:2004-2008.
44. Bjornsson TD, Dryjski M, Tluczek J, Mennie R, Ronan J, Mellin TN, Thomas KA: Acidic fibroblast growth factor promotes vascular repair. Proc Natl Acad Sci USA 1991;88:8651-8655.
45. Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J, Connolly DT: Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 1989;246:1309-1312.
46. Plouet J, Schilling J, Gospodarowicz D: Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT-20 cells. EMBO J 1989;8:3801-3806.
47. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989;246:1306-1309.
48. Connolly DT, Hewelman DM, Nelson R, Olander JV, Eppley BL, Delfino JJ, Siegel RN, Leimgruber RS, Feder J: Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 1989;84:1470-1478.
49. Ferrara N, Henzel WJ: Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 1989;161:851-855.
50. Takeshita S, Zheng LP, Brogi E, Kearney M, Pu LQ, Bunting S, Ferrara N, Symes JF, Isner JM: Therapeutic angiogenesis: A single intra-arterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hindlimb model. J Clin Invest 1994;93:662-670.
51. Banai S, Jaklitsch MT, Shou M, Lazarous DF, Scheinowitz M, Biro S, Epstein SE, Unger EF: Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation 1994;89:2183-2189.
52. Ku DD, Zaleski JK, Liu S, Brock TA: Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. Am J Physiol 1993;265:H586-H592.
53. Peters KG, deVries C, Williams LT: Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc Natl Acad Sci USA 1993;90:8915-8919.
54. Tischer E, Mitchell R, Hartmann T, Silva M, Gospodarowicz D, Fiddes J, Abraham J: The human gene for vascular endothelial growth factor: multiple protein forms are encoded through alternative exon splicing. J Biol Chem 1991;266:11947-11954.
55. Isner JM, Walsh K, Symes JF, Piezcek A, Takeshita S, Lowry J, Rosenfield K, Weir L, Brogi E, Jurayj D: Arterial gene therapy for therapeutic angiogenesis in patients with peripheral artery disease. Circulation 1995;91:2687-2692.
56. Bauters C, Asahara T, Zheng LP, Takeshita S, Bunting S, Ferrara N, Symes JF, Isner JM: Site-specific therapeutic angiogenesis following systemic administration of vascular endothelial growth factor. J Vasc Surg 1995;21:314-325.
57. Takeshita S, Rossow ST, Kearney M, Zheng LP, Bauters C, Bunting S, Ferrara N, Symes JF, Isner JM: Time course of increased cellular proliferation in collateral arteries following administration of vascular endothelial growth factor in a rabbit model of lower limb vascular insufficiency. Am J Pathol (in press)
58. Shen H, Clauss M, Ryan J, Schmidt A-M, Tijburg P, Borden L, Connolly D, Stern D, Kao J: Characterization of vascular permeability factor/vascular endothelial growth factor receptors on mononuclear phagocytes. Blood 1993;81:2767-2773.
59. Clauss M, Gerlach M, Gerlach H, Brett J, Wang F, Familletti PC, Dan Y-CE, Olander JV, Connolly DT, Stern D: Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med 1990;172:1535-1545.
60. Lindner V, Lappi DA, Baird A, Majack RA, Reidy MA: Role of basic fibroblast growth factor in vascular lesion formation. Circ Res 1991;68:106-113.
61. Lindner V, Reidy MA: Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc Natl Acad Sci USA 1991;88:3739-3743.
62. Winkles JA, Frieeesel R, Burgess WH, Howk R, Mehlman T, Weinstein R, Maciag T: Human vascular smooth muscle cells both express and respond to heparin-binding growth factor I (endothelial cell growth factor). Proc Natl Acad Sci USA 1987;84:7124-7128.
63. Fram DB, Aretz T, Azrin MA, Mitchel JF, Samady H, Gillam LD, Sahatjian R, Waters D, McKay RG: Localized intramural drug delivery during balloon angioplasty using hydrogel-coated balloons and pressure-augmented diffusion. JACC 1994;23:1550-1577.
64. Nunes GL, Hanson SR, King III, SB; Sahatjian RA, Scott NA: Local delivery of a synthetic antithrombin with a hydrogen-coated angioplasty balloon catheter inhibits platelet-dependent thrombosis. JACC 1994;23:1578-1583.
65. Chapman GD, Lim CS, Gammon RS, Culp SC, Desper JS, Bauman RP, Swain JL, Stack RS: Gene transfer into coronary arteries of intact animals with a percutaneous ballaoon catheter. Circ Res 1992;71:27-33.
66. Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, Feigner PL: Direct gene transfer into mouse muscle in vivo. Science 1990;247:1465-1468.
67. Wolff JA, Williams P, Acsadi G, Jiao S, Jani A, Chong W: Conditions affecting direct gene transfer into rodent muscle in vivo. Biotechniques 1991;11:474-485.
68. Gal D, Weir L, Leclerc G, Pickering JG, Hogan J, Isner JM: Direct myocardial transfection in two animal models: Evaluation of parameters affecting gene expression and percutaneous gene delivery. Lab Invest 1993;68:18-25.
69. Lin H, Parmacek MS, Morle G, Bolling S, Leiden JM: Expression of recombinant genes in myocardium in vivo after direct injection of DNA. Circulation 1990;82:2217-2221.
70. Kitsis RN, Buttrick PM, McNally EM, Kaplan ML, Leinwand LA: Hormonal modulation of a gene injected into rat heart in vivo. Proc Natl Acad Sci USA 1991;88:4138-4142.
71. Buttrick PM, Kass A, Kitsis RN, Kaplan ML, Leinwand LA: Behavior of genes directly injected into the rat heart in vivo. Circ Res 1992;70:193-198.
72. Leclerc G, Gal D, Takeshita S, Nikol S, Weir L, Isner JM: Percutaneous arterial gene transfer in a rabbit model: Efficiency in normal and balloon-dilated atherosclerotic arteries. J Clin Invest 1992;90:936-944.
73. Lim CS, Chapman GD, Gammon RS, Muhlestein JB, Bauman RP, Stack RS, Swain JL: Direct in vivo gene transfer into the coronary artery and peripheral vasculature of the intact dog. Circulation 1991;83:2007-2011.
74. Willard JE, Landau C, Glamann B, Burns D, Jessen ME, Pirwitz MJ, Gerard RD, Meidell RS: Genetic modification of the vessel wall: comparison of surgical and catheter-based techniques for delivery of recombinant adenovirus. Circulation 1994;89:2190-2197.
75. Stratford-Perricaudet LD, Makeh I, Perricaudet M, Briand P: Widespread long-term gene transfer to mouse skeletal muscles and heart. J Clin Invest 1992;90:626-630.
76. Mulligan R: The basic science of gene therapy. Science 1993;260:926-932.
77. Lemarchand P, Jones M, Yamada I, Crystal RG: In vivo gene transfer and expression in normal uninjured blood vessels using replication-deficient recombinant adenovirus vectors. Circ Res 1993;72:1132-1138.
78. Nabel EG, Plautz G, Nabel GJ: Transduction of a foreign histocompatibility gene into the arterial wall induces vasculitis. Proc Natl Acad Sci USA 1992;89:5157-5161.
79. Nabel EG, Yang Z, Liptay S, San H, Gordon D, Haudenschild CC, Nabel GJ: Recombinant platelet-derived growth factor B gene expression in porcine arteries induces intimai hyperplasia in vivo. J Clin invest 1993;91:1822-1829.
80. Nabel EG, Shum L, Pompili VJ, Yang ZY, San H, Shu HB, Liptay S, Gold L, Gordon D, Derynck R, Nabel GJ: Direct gene transfer of transforming growth factor b1 into arteries stimulates fibrocellular hyperplasia. Proc Natl Acad Sci USA 1993;90: 10759-10763.
81. Takeshita S, Losordo DW, Kearney M, Isner JM: Time course of recombinant protein secretion following liposome-mediated gene transfer in a rabbit arterial organ culture model. Lab Invest 1994;71:387-391.
82. Losordo DW, Pickering JG, Takeshita S, Leclerc G, Gal D, Weir L, Kearney M, Jekanowski J, Isner JM: Use of the rabbit ear artery to serially assess foreign protein secretion after site specific arterial gene transfer in vivo: Evidence that anatomic identification of successful gene transfer may underestimate the potential magnitude of transgene expression. Circulation 1994;89:785-792.
83. Pickering JG, Jekanowski J, Weir L, Takeshita S, Losordo DW, Isner JM: Liposome-mediated gene transfer into human vascular smooth muscle cells. Circulation 1994;89:13-21.
84. Houck KA, Leung DW, Rowland AM, Winer J, Ferrara N: Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem 1992;267: 26031-26037.
85. Tanaka H, Sukhona GK, Swanson SJ, Clinton SK, Ganz P, Cybulsky MI, Libby P: Sustained activation of vascular cells and leukocytes in the rabbit aorta after balloon injury. Circulation 1993;33:1788-1803.
86. Weidinger FF, McLenachan JM, Cybulsky MI, Bordon JB, Rennke HG, Hollenberg NK, Fallon JT, Ganz P, Cooke JP: Persistent dysfunction of regenerated endothelium after balloon angioplasty of rabbit iliac artery. Circulation 1990;81:1667-1679.
87. Riessen R, Rahimizadeh H, Blessing E, Takeshita S, Barry JJ, Isner JM: Arterial gene transfer using pure DNA applied directly to a hydrogel-coated angioplasty balloon. Hum Gene Ther 1993;4:749-758.
88. Takeshita S, Weir L, Zheng LP, Chen D, Riessen R, Bauters C, Symes JF, Ferrara N, Isner JM: Therapeutic angiogenesis following arterial gene transfer of vascular endothelial growth factor in a rabbit model of hindlimb ischemia. Proc Natl Acad Sci USA (In Press)
89. Steele PM, Chesebro JH, Stanton AW, Holmes DR, Dewanjee MK, Badimon L, Fuster V: Balloon angioplasty: natural history of the pathophysiological response to injury in a pig model. Circ Res 1985;57:105-112.
90. Davies MJ, Woolf N, Rrowles PM, Pepper J: Morphology of the endothelium over atherosclerotic plaque in human coronary arteries. Br Heart J 1988;60:459-464.
91. Schwarcz TH, Yates GN, Ghobrial M, Baker WH: Pathologic characteristic of recurrent carotid artery stenosis. J Vasc Surg 1987;5:280-288.
92. Gravanis MB, Roubin GS: Histopathologic phenomena at the site of percutaneous transluminal coronary angioplasty: the problem of restenosis. Human Pathol 1989;20:477-485.
93. Ohno T, Gordon D, San H, Pompili VJ, Imperiale MJ, Nabel GJ, Nabel EG: Gene therapy for vascular smooth muscle cell proliferation after arterial injury. Science 1994;265:781-784.
94. Guzman RJ, Hirschowitz EA, Brody SL, Crystal RG, Epstein SE, Finkel T: In vivo suppression of injury-induced vascular smooth muscle cell accumulation using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene. Proc Natl Acad Sci USA 1994;91:10732-10736.
95. Chang MW, Barr E, Jonathan S, Jiang YQ, Nabel GJ, Nabel EG, Parmacek MS, Leiden JM: Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product. Science 1995;267:518-522.
96. Heiko E, Leyen VD, Gibbons GH, Morishita R, Lewis NP, Zhang L, Nakajima M, Kaneda Y, Coole JP, Dzau VJ: Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cellnitric oxide synthase gene. Proc Natl Acad Sci USA 1995;92:1137-1141.
97. Hiatt WR, Wolfel EE, Meier RH, Regensteiner JG: Superiority of treadmill walking exercise versus strength training for patients with peripheral arterial disease implications for the mechanism of the training response. Circulation 1994;90:1866-1874.
98. Minar E, Ahmadi A, Koppensteiner R, Maca Th, Stumpflen A, Ugurlouglu A, Ehringer H: Comparison of effects of high-dose and low-dose aspirin on restenosis after femoropopliteal percutaneous transluminal angioplasty. Circulation 1995;91:2167-2173.
99. Tanaka M, Herr W: Differential transcriptional activation of Oct-1 and Oct-2: Interdependent activation domains induce Oct-2 phosphorylation. Cell 1990;60:375-386.
100. Nabel G: Proposed amendment to Appendix D of the NIH Guidelines Regarding a Human Gene Therapy Protocol Entitled Immunotherapy of Malignancy by In Vivo Gene Transfer into Tumors. Human Gene Ther 1994;5:236-240.
101. Caplen JJ, Gae X, Hayes P, Elaswarapu R, Fisher G, Kinrade E, Chakera A, Schorr J, Hughes B, Dorin JR, Porteous DJ, Alton EWFW, Geddes DM, Coutelle C, Williamson R, Huang L, Gilchrist C: Gene therapy for cystic fibrosis in humans by liposome mediated DNA transfer: the production of resources and the regulatory process. Gene Therapy 1994;1:139-147.
102. Schleef M, Heimann P: Cesium chloride or column preparation? An electron microscopical view of plasmid preparations. Biotechniques 1993;14:544.
103. Ehlert F, Bierbaum P, Schorr J: Importance of DNA quality for transfection efficiency. Biotechniques 1993;14:546.
104. Acsadi G, Jiao S, Jani A, Duke D, Williams P, Chong W, Wolff JA: Direct gene transfer and expression into rat heart in vivo. The New Biologist 1991;3:71-81.
105. Isner JM: Vascular remodeling: Honey, I think I shrunk the artery. Circulation 1994;89:2937-2941.
106. Mosseri M, Rosenfield K, Losordo DW, Dew R, Harding M, Isner JM: Vasomotor reactivity of lower extremity peripheral vasculature in humans evaluated by intravascular ultrasound. Circulation 1990;82:III-33. (abstract)
107. Isner JM, Kearney M, Bauters C, Leclerc G, Nikol S, Pickering JG, Riessen R, Weir L: Use of human tissue specimens obtained in vivo by directional atherectomy to study restenosis and related human vascular disorders. Trends Cardiovasc Med 1994;4: 213-221.
108. Rutherford RB (Chairman), Flanigan DP, Gupta SK, Johnston KW, Karmody A, Whittemore AD, Baker JD, Ernst CB, Jamieson C (Consultant), Mehta S (Consultant): Prepared by the Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery/North American Chapter, International Society for Cardiovascular Surgery. Suggested standards for reports dealing with lower extremity ischemia. J Vasc Surg 1986;4:90-94.